Finance

Lists
Why is KLRS down 2,75%?
Dive Deeper
KLRS:NASDAQ
Kalaris Therapeutics Inc
2,30 $
-2,75%
(-0,065) 1D
12 հոկ, 12:25:11 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRS...
Open
2,37 $
High
2,37 $
Low
2,25 $
Mkt. cap
54,63 մլն
Avg. vol.
74,92 հզր
Volume
81,18 հզր
52-wk high
11,88 $
52-wk low
2,25 $
EPS
-2,09 $
Beta
0,42
Shares outstanding
23,80 մլն
No. of employees
20
Open
2,37 $
High
2,37 $
Low
2,25 $
Mkt. cap
54,63 մլն
Avg. vol.
74,92 հզր
Volume
81,18 հզր
52-wk high
11,88 $
52-wk low
2,25 $
EPS
-2,09 $
Beta
0,42
Shares outstanding
23,80 մլն
No. of employees
20
News stories
From web sources and news partners
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersԲերքլի Հեյթս, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websitekalaristx.com
Analyst ratings
Based on 3 analysts giving stock ratings to KLRS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for KLRS in the last 3 months.
Highest
Current 2,30 $
17,00 $ (+640,74%)
Average
15,50 $ (+575,38%)
Lowest
14,00 $ (+510,02%)
Analyst
Recommendation
Action
Price target
Projected
Date
Judah Frommer
Morgan Stanley
Buy
Reiterated
14,00 $
+510%
08/12/2026
Yun Zhong
Wedbush
Buy
Reiterated
17,00 $
+640,7%
08/11/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
08/11/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
06/15/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
25,00 $
+989,3%
05/13/2026
Biren Amin
Piper Sandler
Hold
Maintained
7,00 $
+205%
03/30/2026
Daniil Gataulin
Chardan Capital
Buy
Initiated
19,00 $
+727,9%
12/23/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,13 մլն
7,16 մլն
7,57 մլն
9,02 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,62 մլն
3,64 մլն
4,26 մլն
3,37 մլն
Operating expense
12,74 մլն
10,80 մլն
11,83 մլն
12,39 մլն
Total operating expenses
12,74 մլն
10,80 մլն
11,83 մլն
12,39 մլն
Operating income
-12,74 մլն
-10,80 մլն
-11,83 մլն
-12,39 մլն
Other non operating income
847,00 հզր
803,00 հզր
977,00 հզր
871,00 հզր
EBT including unusual items
-11,89 մլն
-10,00 մլն
-10,86 մլն
-11,52 մլն
EBT excluding unusual items
-11,89 մլն
-10,00 մլն
-10,86 մլն
-11,52 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,89 մլն
-10,00 մլն
-10,86 մլն
-11,52 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,64
-0,44
-0,46
-0,48
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,74 մլն
-10,79 մլն
-11,82 մլն
-12,38 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps